{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:08:57Z","timestamp":1789420137347,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jconrel.2024.07.050","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T07:05:37Z","timestamp":1722236737000},"page":"547-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1 magnetic resonance imaging"],"prefix":"10.1016","volume":"373","author":[{"given":"Yike","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangsen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Zubair","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.07.050_bb0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","article-title":"Current and next generation influenza vaccines: Formulation and production strategies","volume":"94","author":"Soema","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.050_bb0010","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.050_bb0015","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.7150\/ijbs.59233","article-title":"mRNA vaccines for COVID-19: What, why and how","volume":"17","author":"Park","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.actbio.2021.06.023","article-title":"From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases","volume":"131","author":"Pilkington","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2020.12.014","article-title":"Self-assembled mRNA vaccines","volume":"170","author":"Kim","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.050_bb0030","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: The next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: Pros, cons and beyond","volume":"124","author":"Tan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.050_bb0040","article-title":"Attenuating metabolic competition of tumor cells for favoring the nutritional demand of immune cells by a branched polymeric drug delivery system","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mat. (Deerfield Beach Fla)"},{"issue":"6382","key":"10.1016\/j.jconrel.2024.07.050_bb0045","doi-asserted-by":"crossref","first-page":"1350-+","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.050_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.050_bb0055","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccell.2022.05.015","article-title":"Cancer vaccines","volume":"40","author":"Schiller","year":"2022","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0060","article-title":"Cancer vaccines: Past, present and future; A review article","volume":"13","author":"Grimmett","year":"2022","journal-title":"Discov. Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.050_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/cells12121606","article-title":"Recent advances in CAR-based solid tumor immunotherapy","volume":"12","author":"Shin","year":"2023","journal-title":"Cells"},{"issue":"6382","key":"10.1016\/j.jconrel.2024.07.050_bb0070","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.050_bb0075","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.apsb.2021.12.021","article-title":"Emerging vaccine nanotechnology: From defense against infection to sniping cancer","volume":"12","author":"Feng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"Suppl. 3","key":"10.1016\/j.jconrel.2024.07.050_bb0080","first-page":"S3\/106","article-title":"Chapter 12: prophylactic HPV vaccines: underlying mechanisms","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.050_bb0085","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1021\/acsbiomaterials.0c01201","article-title":"Therapeutic vaccines for Cancer immunotherapy","volume":"6","author":"Wang","year":"2020","journal-title":"ACS Biomater Sci. Eng."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.050_bb0090","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.jconrel.2024.07.050_bb0100","article-title":"Impairing tumor metabolic plasticity via a stable metal-phenolic-based polymeric nanomedicine to suppress colorectal Cancer","volume":"35","author":"Li","year":"2023","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"issue":"30","key":"10.1016\/j.jconrel.2024.07.050_bb0105","article-title":"From design to clinic: Engineered Nanobiomaterials for immune normalization therapy of Cancer","volume":"33","author":"Saeed","year":"2021","journal-title":"Adv. Mater. (Deerfield Beach Fla)"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.07.050_bb0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-4347(01)00108-6","article-title":"Structure and properties of ovalbumin","volume":"756","author":"Huntington","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0115","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3892\/or.2014.3603","article-title":"Vaccination with OVA-bound nanoparticles encapsulating IL-7 inhibits the growth of OVA-expressing E.G7 tumor cells in vivo","volume":"33","author":"Toyota","year":"2015","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1747","article-title":"Endotoxin contamination in ovalbumin as viewed from a nano-immunotherapy perspective","volume":"14","author":"Pang","year":"2021","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.050_bb0125","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1039\/D2CS00647B","article-title":"Materials engineering strategies for cancer vaccine adjuvant development","volume":"52","author":"Zhang","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.050_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1590","article-title":"Nanotechnology platforms for cancer immunotherapy","volume":"12","author":"Yang","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.050_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1039\/D2MH01358D","article-title":"Polymeric nanoparticle-based nanovaccines for cancer immunotherapy","volume":"10","author":"Zhang","year":"2023","journal-title":"Mater. Horiz."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.050_bb0140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3322\/caac.21713","article-title":"Molecular imaging in oncology: Current impact and future directions","volume":"72","author":"Rowe","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0145","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-018-0130-1","article-title":"Theranostics and contrast agents for magnetic resonance imaging","volume":"22","author":"Jeong","year":"2018","journal-title":"Biomater. Res."},{"issue":"25","key":"10.1016\/j.jconrel.2024.07.050_bb0150","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.1002\/anie.201510956","article-title":"What we can really do with bioresponsive MRI contrast agents","volume":"55","author":"Angelovski","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202205109","article-title":"Facile synthesis of weakly ferromagnetic Organogadolinium macrochelates-based T1-weighted magnetic resonance imaging contrast agents","volume":"10","author":"Lu","year":"2022","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.050_bb0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","article-title":"Gadolinium deposition in the brain: Summary of evidence and recommendations","volume":"16","author":"Gulani","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0165","article-title":"Magnetic nanoparticles: A review on synthesis, characterization, functionalization, and biomedical applications","author":"Rezaei","year":"2023","journal-title":"Small"},{"issue":"23","key":"10.1016\/j.jconrel.2024.07.050_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201906539","article-title":"Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: Fundamentals, challenges, applications, and Prospectives","volume":"33","author":"Jeon","year":"2020","journal-title":"Adv. Mater."},{"issue":"10","key":"10.1016\/j.jconrel.2024.07.050_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201905823","article-title":"Manganese oxide nanomaterials: Synthesis, properties, and theranostic applications","volume":"32","author":"Ding","year":"2020","journal-title":"Adv. Mater."},{"issue":"1\u20133","key":"10.1016\/j.jconrel.2024.07.050_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/ars.2021.0110","article-title":"Nitroxyl radical as a theranostic contrast agent in magnetic resonance redox imaging","volume":"36","author":"Matsumoto","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0185","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.2147\/IJN.S171804","article-title":"Nitroxide-radicals–modified gold nanorods for in vivo CT\/MRI-guided photothermal cancer therapy","volume":"13","author":"Xia","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.050_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.mri.2004.11.031","article-title":"Hyperpolarization of 13C through order transfer from parahydrogen: a new contrast agent for MRI","volume":"23","author":"Goldman","year":"2005","journal-title":"Magn. Reson. Imaging"},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.050_bb0195","doi-asserted-by":"crossref","first-page":"8483","DOI":"10.1021\/acsnano.3c00694","article-title":"Fluoropolymer-MOF hybrids with switchable hydrophilicity for 19F MRI-monitored Cancer therapy","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.050_bb0200","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1002\/anie.202011513","article-title":"A novel class of 1H-MRI contrast agents based on the relaxation enhancement induced on water protons by 14N-containing imidazole moieties","volume":"60","author":"Baroni","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.050_bb0205","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1021\/acs.bioconjchem.9b00499","article-title":"The transition from metal-based to metal-free contrast agents for T1 magnetic resonance imaging enhancement","volume":"30","author":"Akakuru","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.050_bb0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1021\/acscentsci.7b00308","article-title":"Building a better magnetic resonance imaging contrast agent using macromolecular architecture","volume":"3","author":"Zhou","year":"2017","journal-title":"ACS Cent. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.050_bb0215","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mabi.201400403","article-title":"Organic radical contrast agents based on Polyacetylenes containing 2,2,6,6-Tetramethylpiperidine 1-Oxyl (TEMPO): Targeted magnetic resonance (MR)\/optical bimodal imaging of folate receptor expressing HeLa tumors in vitro and in Vivoa","volume":"15","author":"Huang","year":"2015","journal-title":"Macromol. Biosci."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.050_bb0220","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1039\/C7SM02292A","article-title":"Microwave-assisted synthesis of TEMPO-labeled hydrogels traceable with MRI","volume":"14","author":"Mauri","year":"2018","journal-title":"Soft Matter"},{"issue":"12","key":"10.1016\/j.jconrel.2024.07.050_bb0225","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1039\/D1CC06158E","article-title":"Rotaxane-branched radical dendrimers with TEMPO termini","volume":"58","author":"Peng","year":"2022","journal-title":"Chem. Commun."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.050_bb0230","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1021\/acsnano.0c09590","article-title":"Metal-free organo-theranostic nanosystem with high nitroxide stability and loading for image-guided targeted tumor therapy","volume":"15","author":"Akakuru","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/srep38348","article-title":"In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy","volume":"6","author":"Han","year":"2016","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.jconrel.2024.07.050_bb0240","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1039\/C7RA13510F","article-title":"A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing","volume":"8","author":"Liu","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116800","article-title":"A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers","volume":"250","author":"Rasul","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.050_bb0250","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jfda.2014.10.008","article-title":"Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review","volume":"23","author":"Elgadir","year":"2015","journal-title":"J. Food Drug Anal."},{"issue":"24","key":"10.1016\/j.jconrel.2024.07.050_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300171","article-title":"In situ STING-activating nanovaccination with TIGIT blockade for enhanced immunotherapy of anti-PD-1-resistant tumors","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"issue":"31","key":"10.1016\/j.jconrel.2024.07.050_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207697","article-title":"In situ cocktail nanovaccine for cancer immunotherapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0265","article-title":"Organoid model: A new hope for pancreatic cancer treatment?","volume":"1875","author":"Chen","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"33","key":"10.1016\/j.jconrel.2024.07.050_bb0270","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1039\/D1TB01097B","article-title":"Facile synthesis of biocompatible magnetic titania nanorods for T1-magnetic resonance imaging and enhanced phototherapy of cancers","volume":"9","author":"Iqbal","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.050_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05042-x","article-title":"High-content imaging of human hepatic spheroids for researching the mechanism of duloxetine-induced hepatotoxicity","volume":"13","author":"Liu","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0280","article-title":"Hepatic organoid-based high-content imaging boosts evaluation of stereoisomerism-dependent hepatotoxicity of stilbenes in herbal medicines","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.050_bb0285","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ijc.30102","article-title":"Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging","volume":"139","author":"Onda","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"25","key":"10.1016\/j.jconrel.2024.07.050_bb0290","article-title":"An indocyanine green-based nanoprobe for in vivo detection of cellular senescence","volume":"63","author":"Baker","year":"2024","journal-title":"Angew. Chem. Int. Ed. Eng."},{"issue":"18","key":"10.1016\/j.jconrel.2024.07.050_bb0295","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301339","article-title":"Biomaterials facilitating dendritic cell-mediated cancer immunotherapy","volume":"10","author":"Dong","year":"2023","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2024.07.050_bb0300","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.jconrel.2024.07.050_bb0305","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1039\/D2CS00848C","article-title":"Adjuvant physiochemistry and advanced nanotechnology for vaccine development","volume":"52","author":"Ren","year":"2023","journal-title":"Chem. Soc. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.050_bb0310","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0952-7915(02)00317-5","article-title":"Prophylactic cancer vaccines","volume":"14","author":"Finn","year":"2002","journal-title":"Curr. Opin. Immunol."},{"issue":"27","key":"10.1016\/j.jconrel.2024.07.050_bb0315","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.2174\/138161205774414565","article-title":"Therapeutic vaccines for cervical cancer: Dendritic cell-based immunotherapy","volume":"11","author":"Santin","year":"2005","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.jconrel.2024.07.050_bb0320","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2024.07.050_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121794","article-title":"A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy","volume":"289","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.050_bb0330","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.jconrel.2024.07.050_bb0335","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1039\/D1BM00508A","article-title":"Inorganic material based macrophage regulation for cancer therapy: Basic concepts and recent advances","volume":"9","author":"Zhao","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.07.050_bb0340","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4614-8244-4_10","article-title":"Syngeneic murine metastasis models: B16 melanoma","volume":"vol. 1070","author":"Giavazzi","year":"2014","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924005054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924005054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T16:56:08Z","timestamp":1725728168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924005054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":68,"alternative-id":["S0168365924005054"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.050","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1 magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}